3 times QC before delivery.
12-month shelf life.
Strong technical support
Prompt response
After-sales service guarantee.
Our technical team will regularly release the latest study and objective testing results as well. We will also keep our partners or end-users upated of our new testing technique.
Complement Factor B: An Important Regulatory Factor for Protecting the Body's Immune System
Complement Factor B: An Important Regulatory Factor for Protecting the Body s Immune System...[Read More]
Soluble CD5: An Immune Activation Biomarker and Its Quantitative Detection by ELISA
Soluble CD5: An Immune Activation Biomarker and Its Quantitative Detection by ELISA...[Read More]
The application, advantages and future prospects of ELISA technology
The application, advantages and future prospects of ELISA technology...[Read More]
Resolvin D1 (RvD1): A Key Lipid Mediator in the Inflammation Resolution Pathway
Resolvin D1 (RvD1): A Key Lipid Mediator in the Inflammation Resolution Pathway...[Read More]
Ferritin: Its Structure, Biological Functions, and Biomedical Applications
Ferritin: Its Structure, Biological Functions, and Biomedical Applications ...[Read More]
Glutathione Peroxidase 4 (GPX4): Molecular Mechanisms, Ferroptosis Control, and Therapeutic Potential
Glutathione Peroxidase 4 (GPX4): Molecular Mechanisms, Ferroptosis Control, and Therapeutic Potential...[Read More]
Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)...[Read More]
Sestrin2 (SESN2): A Stress-Sensing Protein Linking Redox Control, mTOR Signaling, Ferroptosis, ER-Phagy, and Reproductive Protection
Sestrin2 (SESN2): A Stress-Sensing Protein Linking Redox Control, mTOR Signaling, Ferroptosis, ER-Phagy, and Reproductive Protection...[Read More]
Decoding the Immune "Signal Messenger" IFN-γ: A Comprehensive Perspective from Molecular Mechanisms to Clinical Applications
Decoding the Immune "Signal Messenger " IFN-γ: A Comprehensive Perspective from Molecular Mechanisms to Clinical Applications...[Read More]
